Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109


The transcriptome that mediates increased cyclic adenosine monophosphate signaling in PRKAR1A defects and other settings.

Azevedo MF, Stratakis CA.

Endocr Pract. 2011 Jul-Aug;17 Suppl 3:2-7. doi: 10.4158/EP10412.RA. Review.


PRKAR1A mutations in primary pigmented nodular adrenocortical disease.

Cazabat L, Ragazzon B, Groussin L, Bertherat J.

Pituitary. 2006;9(3):211-9. Review.


PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex.

Robinson-White A, Meoli E, Stergiopoulos S, Horvath A, Boikos S, Bossis I, Stratakis CA.

J Clin Endocrinol Metab. 2006 Jun;91(6):2380-8. Epub 2006 Mar 28.


Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.

Gaujoux S, Tissier F, Groussin L, Libé R, Ragazzon B, Launay P, Audebourg A, Dousset B, Bertagna X, Bertherat J.

J Clin Endocrinol Metab. 2008 Oct;93(10):4135-40. doi: 10.1210/jc.2008-0631. Epub 2008 Jul 22.


How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?

Almeida MQ, Stratakis CA.

Mol Cell Endocrinol. 2011 Apr 10;336(1-2):162-8. doi: 10.1016/j.mce.2010.11.018. Epub 2010 Nov 25. Review.


17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.

Bourdeau I, Matyakhina L, Stergiopoulos SG, Sandrini F, Boikos S, Stratakis CA.

J Clin Endocrinol Metab. 2006 Sep;91(9):3626-32. Epub 2006 Jun 13.


Protein kinase A and its role in human neoplasia: the Carney complex paradigm.

Bossis I, Voutetakis A, Bei T, Sandrini F, Griffin KJ, Stratakis CA.

Endocr Relat Cancer. 2004 Jun;11(2):265-80. Review.


Inactivation of the Carney complex gene 1 (PRKAR1A) alters spatiotemporal regulation of cAMP and cAMP-dependent protein kinase: a study using genetically encoded FRET-based reporters.

Cazabat L, Ragazzon B, Varin A, Potier-Cartereau M, Vandier C, Vezzosi D, Risk-Rabin M, Guellich A, Schittl J, Lechêne P, Richter W, Nikolaev VO, Zhang J, Bertherat J, Vandecasteele G.

Hum Mol Genet. 2014 Mar 1;23(5):1163-74. doi: 10.1093/hmg/ddt510. Epub 2013 Oct 10.


New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors.

Stratakis CA.

Mol Cell Endocrinol. 2009 Mar 5;300(1-2):152-7. doi: 10.1016/j.mce.2008.11.010. Epub 2008 Nov 21. Review.


Carney complex and other conditions associated with micronodular adrenal hyperplasias.

Almeida MQ, Stratakis CA.

Best Pract Res Clin Endocrinol Metab. 2010 Dec;24(6):907-14. doi: 10.1016/j.beem.2010.10.006.


Human tumors associated with Carney complex and germline PRKAR1A mutations: a protein kinase A disease!

Stergiopoulos SG, Stratakis CA.

FEBS Lett. 2003 Jul 3;546(1):59-64. Review.


Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations.

Almeida MQ, Azevedo MF, Xekouki P, Bimpaki EI, Horvath A, Collins MT, Karaviti LP, Jeha GS, Bhattacharyya N, Cheadle C, Watkins T, Bourdeau I, Nesterova M, Stratakis CA.

J Clin Endocrinol Metab. 2012 Apr;97(4):E687-93. doi: 10.1210/jc.2011-3000. Epub 2012 Jan 18.


Differences in adiposity in Cushing syndrome caused by PRKAR1A mutations: clues for the role of cyclic AMP signaling in obesity and diagnostic implications.

London E, Rothenbuhler A, Lodish M, Gourgari E, Keil M, Lyssikatos C, de la Luz Sierra M, Patronas N, Nesterova M, Stratakis CA.

J Clin Endocrinol Metab. 2014 Feb;99(2):E303-10. doi: 10.1210/jc.2013-1956. Epub 2013 Nov 18.


Clinical and molecular genetics of primary pigmented nodular adrenocortical disease.

Sandrini F, Stratakis C.

Arq Bras Endocrinol Metabol. 2004 Oct;48(5):637-41. Epub 2005 Mar 7. Review.


Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.

Ragazzon B, Cazabat L, Rizk-Rabin M, Assie G, Groussin L, Fierrard H, Perlemoine K, Martinez A, Bertherat J.

Cancer Res. 2009 Sep 15;69(18):7278-84. doi: 10.1158/0008-5472.CAN-09-1601. Epub 2009 Sep 8.


mTOR pathway is activated by PKA in adrenocortical cells and participates in vivo to apoptosis resistance in primary pigmented nodular adrenocortical disease (PPNAD).

de Joussineau C, Sahut-Barnola I, Tissier F, Dumontet T, Drelon C, Batisse-Lignier M, Tauveron I, Pointud JC, Lefrançois-Martinez AM, Stratakis CA, Bertherat J, Val P, Martinez A.

Hum Mol Genet. 2014 Oct 15;23(20):5418-28. doi: 10.1093/hmg/ddu265. Epub 2014 May 27.


Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes.

Bimpaki EI, Nesterova M, Stratakis CA.

Eur J Endocrinol. 2009 Jul;161(1):153-61. doi: 10.1530/EJE-09-0027. Epub 2009 May 8.


Functional Characterization of PRKAR1A Mutations Reveals a Unique Molecular Mechanism Causing Acrodysostosis but Multiple Mechanisms Causing Carney Complex.

Rhayem Y, Le Stunff C, Abdel Khalek W, Auzan C, Bertherat J, Linglart A, Couvineau A, Silve C, Clauser E.

J Biol Chem. 2015 Nov 13;290(46):27816-28. doi: 10.1074/jbc.M115.656553. Epub 2015 Sep 24.


Adrenal pathophysiology: lessons from the Carney complex.

Groussin L, Cazabat L, René-Corail F, Jullian E, Bertherat J.

Horm Res. 2005;64(3):132-9. Epub 2005 Sep 27. Review.

Items per page

Supplemental Content

Write to the Help Desk